TABLE 3.

Clinical outcomes based on presumed source of infection

Patient group, source of infection, and outcome	No. of indicated outcome/total no. (%)		P
	EI PTZ	SI PTZ
All patients
Pulmonary
Death	53/371 (14.3)	10/95 (10.5)	0.403
Clinical failure	90/371 (24.3)	16/95 (16.8)	0.168
Urinary
Death	2/80 (2.5)	5/30 (16.7)	0.016a
Clinical failure	5/80 (6.3)	8/30 (26.7)	0.006a
Intra-abdominal
Death	8/110 (7.3)	6/32 (18.8)	0.086
Clinical failure	16/110 (14.5)	8/32 (25.0)	0.184
Skin and soft tissue
Death	6/62 (9.7)	3/16 (18.8)	0.380
Clinical failure	9/62 (14.5)	2/16 (12.5)	1
Bloodstream
Death	3/24 (12.5)	0/4 (0)	1
Clinical failure	1/24 (4.2)	0/4 (0)	1
Other
Death	0/15 (0)	1/4 (25.0)	1
Clinical failure	1/15 (6.7)	1/4 (25.0)	0.386
ICU patients
Pulmonary
Death	52/306 (17.0)	9/78 (11.5)	0.299
Clinical failure	81/306 (26.5)	15/78 (19.2)	0.240
Urinary
Death	2/47 (4.3)	5/22 (22.7)	0.030a
Clinical failure	3/47 (6.4)	8/22 (36.4)	0.003a
Intra-abdominal
Death	8/80 (10.0)	6/22 (27.3)	0.073
Clinical failure	14/80 (17.5)	7/22 (31.8)	0.149
Skin and soft tissue
Death	5/34 (14.7)	3/13 (23.1)	0.666
Clinical failure	9/34 (26.5)	2/13 (15.4)	0.702
Bloodstream
Death	3/18 (16.7)	0/1 (0)	1
Clinical failure	1/18 (5.6)	0/1 (0)	1
Other
Death	0/8 (0)	0/2 (0)	1
Clinical failure	1/8 (12.5)	1/2 (50.0)	0.378

^aReached statistical significance.